Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MetaStat Inc MTST

Healthcare Technology Biotechnology Scientific & Technical Instruments
MetaStat, Inc. is a precision medicine company. The Company's therapeutic focus targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. The Company's product development programs are focused on developing drug candidates and companion diagnostic tests that target the MENA pathway. Its pipelines include MENA Diagnostic... see more

Recent & Breaking News (GREY:MTST)

MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations

Business Wire July 16, 2018

MetaStat Presents Positive Data Showing Inhibition of the MENA-pathway Reduces Cancer Cell Dissemination and Paclitaxel Resistance in Aggressive Cancer

Business Wire June 21, 2018

MetaStat Announces Positive Topline Data Showing Over 50% Reduction in Cancer Metastasis from Preclinical Studies Evaluating Inhibition of the MAPKAPK2 Kinase Pathway

Business Wire February 28, 2018

MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations

Business Wire September 25, 2017

MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board

Business Wire August 3, 2017

Study Demonstrates Paclitaxel Treatment Promotes Breast Cancer Dissemination and Metastasis in a Mena-dependent Manner

Business Wire July 19, 2017

MetaStat Closes First Round of a $7 Million Private Placement

Business Wire June 27, 2017

MetaStat Announces Completion of Second Milestone of its Pilot Research Project with Celgene Corporation

Business Wire June 19, 2017

MetaStat Expands Therapeutic and Companion Diagnostic Intellectual Property Portfolio

Business Wire May 23, 2017

MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors

Business Wire May 8, 2017

Mena Expression is Associated with Paclitaxel-mediated Increase in Cancer Cell Dissemination

Business Wire April 6, 2017

MetaStat to Present at the 19th Annual BIO CEO & Investor Conference

Business Wire February 8, 2017

MetaStat, Inc. to Present at Biotech Showcase™ 2017

Business Wire January 9, 2017

MetaStat Receives Additional State Clinical Laboratory Licenses

Business Wire December 19, 2016

MetaStat Presents Positive Data from Two Clinical Studies of MetaSite Breast™ at 2016 San Antonio Breast Cancer Symposium

Business Wire December 13, 2016

MetaStat, Inc. Closes Private Placement of Common Stock and Warrants

Business Wire October 27, 2016

MetaStat, Inc. to Present at the 2016 BIO Investor Forum in San Francisco

Business Wire October 19, 2016

MetaStat, Inc. to Present at SeeThruEquity Fall Microcap Investor Conference in New York City

Business Wire October 17, 2016

MetaStat Announces Presentation of Two MetaSite Breast™ Studies at the 2016 San Antonio Breast Cancer Symposium

Business Wire August 29, 2016

Celgene Corporation (NASDAQ: CELG) CMO Joins MetaStat Inc (OTCQB: MTST) Board

Accesswire April 27, 2016